A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg

Clinical trial NCT04987970 · COMPLETED

Trial details

NCT number: NCT04987970
Sponsor: Chong Kun Dang Pharmaceutical
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypertension and Dyslipidemia

Start date: 2021-09-12
Primary completion: 2021-11-11
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.